|
|
||||||||
Clinical Chemistry, Vol 41, 858-861, Copyright © 1995 by American Association for Clinical Chemistry
P Bean, MS Sutphin, Y Liu, R Anton, TB Reynolds, Y Shoenfeld and JB Peter
Specialty Laboratories, Inc., Santa Monica, CA 90404-3900, USA.
Primary biliary cirrhosis (PBC) is one of the few nonalcohol-induced liver pathologies that causes false positives in assays of carbohydrate- deficient transferrin (CDT) for diagnosing alcohol abuse. CDT was quantified by isoelectric focusing-immunoblotting-laser densitometry (IEF-IB-LD) analysis of serum from 117 women: 57 PBC patients, 20 alcohol abusers, and 40 healthy donors. Only 5% (3 of 57) of PBC patients were positive at the densitometric cutoff value chosen (> 90% specificity). Serum samples from 15 PBC patients were further evaluated by IEF-IB-LD and CDTect chromatography-RIA. Receiver-operating characteristic (ROC) analysis showed that IEF-IB-LD better discriminated between PBC and alcohol abuse than CDTect did. By ROC analysis, mitochondrial autoantibodies to pyruvate dehydrogenase antigen M2 detected by enzyme immunoassay yielded optimal test performance for diagnosing PBC. Of six patients falsely positive for CDT by CDTect, five (83%) tested M2-positive. Thus, abnormal CDT results should be further evaluated by mitochondrial antibody testing in patients with findings compatible with PBC.
The following articles in journals at HighWire Press have cited this article:
![]() |
C. Perez-Cerda, D. Quelhas, A. I. Vega, J. Ecay, L. Vilarinho, and M. Ugarte Screening Using Serum Percentage of Carbohydrate-Deficient Transferrin for Congenital Disorders of Glycosylation in Children with Suspected Metabolic Disease Clin. Chem., January 1, 2008; 54(1): 93 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Helander, G. Eriksson, H. Stibler, and J.-O. Jeppsson Interference of Transferrin Isoform Types with Carbohydrate-deficient Transferrin Quantification in the Identification of Alcohol Abuse Clin. Chem., July 1, 2001; 47(7): 1225 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Arndt Carbohydrate-deficient Transferrin as a Marker of Chronic Alcohol Abuse: A Critical Review of Preanalysis, Analysis, and Interpretation Clin. Chem., January 1, 2001; 47(1): 13 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Helander, E. Vabo, K. Levin, and S. Borg Intra- and interindividual variability of carbohydrate-deficient transferrin, {gamma}-glutamyltransferase, and mean corpuscular volume in teetotalers Clin. Chem., October 1, 1998; 44(10): 2120 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Arndt, R. Hackler, T. O. Kleine, and A. M. Gressner Validation by isoelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of carbohydrate-deficient transferrin by the CDTect assay Clin. Chem., January 1, 1998; 44(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Arndt, R. Hackler, T. Muller, T. O. Kleine, and A. M. Gressner Increased serum concentration of carbohydrate-deficient transferrin in patients with combined pancreas and kidney transplantation Clin. Chem., February 1, 1997; 43(2): 344 - 351. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |